Pair of R&D updates bolster GSK ahead of investor meetingGlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop Share XPair of R&D updates bolster GSK ahead of investor meetinghttps://pharmaphorum.com/news/pair-of-rd-updates-bolster-gsk-ahead-of-investor-meeting/
Halozyme abandons cancer R&D as lead drug failedUS biotech Halozyme has been forced to cut more than half its workforce and exit cancer R&D after Share XHalozyme abandons cancer R&D as lead drug failedhttps://pharmaphorum.com/news/halozyme-abandons-cancer-rd-as-lead-drug-failed/
